Anniversary Index

25th Years of Innovation

2020

First Vaccine For The Prevention Of COVID-19 To Receive Conditional Marketing Authorization From The European Medicines Agency: COMIRNATY® (BNT162b2/Pfizer-BioNTech COVID-19 Vaccine)

First Large Scale Application Of AI To Protein Structure Determination: AlfaFold

2019

Large Scale Microbial Production Of Next Generation, Zero-Calorie, Non-Artificial EVERSWEET™ Stevia Sweetener

2018

European “1+ Million Genomes” Initiative Launched

First CAR-T Cell Therapy, Kymriah® Second FDA Approval And EC Approval – Unique To Each Patient

Autologous CAR-T Cell Therapy Kymriah – Unique To Each Patient. First EC Approval For Two Indications (PALL And DLBCL)

2017

First Radioligand Therapy (RLT) Approved In Europe For The Treatment Of Gastroenteropancreatic Neuroendocrine Tumours – Lutathera®

2016

First Curative Gene Therapy For ADA-SCID Approved For Infants

World’s First Industrial Scale Plant For Production Of Butanediol (1,4 BDO) From Renewable Materials Via Biosynthesis (Fermentation From Micro-Organisms)

2015

It’s Coming…

2014

First Industrial Fermentation-Derived Perfume Ingredient Clearwood®

Checkpoint Inhibitor Innovation As Key Part Of Cancer Immunotherapy

2013

First Approved Cancer Treatment Using Antibody Glycosylation (GlycoMAb) – Gazyvaro

2012

Collaborative Patient Partnership Delivers First Treatment Approved In Europe For Genetic Disease, Alkaptonuria (AKU)

2011

It’s Coming…

2010

It’s Coming…

2009

It’s Coming…

2008

It’s Coming…

2007

Landmark European Publication Behind ‘Knowledge Based Bioeconomy’ In Europe

First Production Of Spider Silk Through Biotechnology

Trabectedin (ET-743, Yondelis®) First Anti-Cancer Drug From Marine Origins Approved In Europe

2006

Revolution In HIV Treatment. First EMA Approval For Single Tablet Regimen Taken Once A Day

Globally Accessible Gene Sequencing Technology

2005

Europe’s Largest Medicines Biotechnology Facilities Open: Pfizer Grange Castle, Dublin

2004

It’s Coming…

2003

Human Genome Project Completion

Targeting Regulation Of Protein Production For New Medicines

2002

CRISPR-Cas Genome Editing Technology

2001

First Enzyme Replacement Therapy For To Treat Fabry Disease Approved In The European Union, Plus World’s Largest Database Of Fabry Disease Patients

2000

Provitamin A Enriched “Golden Rice” To Combat Vitamin A Deficiency And Blindness

Vitamin B2 Shifts From Chemical Synthesis To Exclusive Biotechnological Production In Less Than 15 Years

1999

Messenger RNA (mRNA) patented in relation to therapeutic applications

1998

It’s Coming…

1997

First Clinical Trial With D2E7 (Humira), The First Fully Human Monoclonal Antibody Approved By The US Food And Drug Administration (FDA)

1996

Understanding How The Immune System Recognises Virus-Infected Cells. Nobel Prize For Physiology Or Medicine

First European Commission-Approved Product Following European Agency For The Evaluation Of Medicinal Products (EMEA, Later EMA) Recommendation

Introduction Of Law In Italy For Early Access To Drugs (648/1996) To Support Rare Disease Patients

2020

First Vaccine For The Prevention Of COVID-19 To Receive Conditional Marketing Authorization From The European Medicines Agency: COMIRNATY® (BNT162b2/Pfizer-BioNTech COVID-19 Vaccine)

First Large Scale Application Of AI To Protein Structure Determination: AlfaFold

2020

BIOTECH NEWSLETTER

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!

FOLLOW US HERE

Keep up with what is happening in the Biotech sector by connecting with us on social media!

BIOTECH NEWSLETTER

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!